IGF2BP3 regulated SCD mRNA m6A modifications via IGF2BP3–METTL14 complex, thereby enhancing cervical cancer proliferation, metastasis, and lipid metabolism [144]. The gene discussed is IGF2BP3; the disease is cervical cancer.